Lichtenstein GR - Search Results

1

Baidoo L, Lichtenstein GR. Baidoo L, et al. Among authors: lichtenstein gr. Am J Gastroenterol. 2005 Jan;100(1):80-3. doi: 10.1111/j.1572-0241.2005.41716.x. Am J Gastroenterol. 2005. PMID: 15654785

2

The relationship between infliximab treatment and lymphoma in Crohn's disease.

Bickston SJ, Lichtenstein GR, Arseneau KO, Cohen RB, Cominelli F. Bickston SJ, et al. Among authors: lichtenstein gr. Gastroenterology. 1999 Dec;117(6):1433-7. doi: 10.1016/s0016-5085(99)70294-5. Gastroenterology. 1999. PMID: 10579985 Review.

3

Therapeutic potential of infliximab in inflammatory bowel disease.

Hurd LB, Lichtenstein GR. Hurd LB, et al. Among authors: lichtenstein gr. Gastroenterol Nurs. 1999 Sep-Oct;22(5):199-208. doi: 10.1097/00001610-199909000-00003. Gastroenterol Nurs. 1999. PMID: 10776108 Review.

4

Integrating anti-tumor necrosis factor therapy in inflammatory bowel disease: current and future perspectives.

Blam ME, Stein RB, Lichtenstein GR. Blam ME, et al. Among authors: lichtenstein gr. Am J Gastroenterol. 2001 Jul;96(7):1977-97. doi: 10.1111/j.1572-0241.2001.03931.x. Am J Gastroenterol. 2001. PMID: 11467623 Review.

5

Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis.

Su C, Salzberg BA, Lewis JD, Deren JJ, Kornbluth A, Katzka DA, Stein RB, Adler DR, Lichtenstein GR. Su C, et al. Among authors: lichtenstein gr. Am J Gastroenterol. 2002 Oct;97(10):2577-84. doi: 10.1111/j.1572-0241.2002.06026.x. Am J Gastroenterol. 2002. PMID: 12385442

6

Maintenance infliximab therapy in patients with Crohn's disease: how long, how much, how frequent?

Cuffari C, Lichtenstein GR. Cuffari C, et al. Among authors: lichtenstein gr. Gastroenterology. 2003 Jun;124(7):1988-90. doi: 10.1016/s0016-5085(03)00569-9. Gastroenterology. 2003. PMID: 12806638 No abstract available.

7

Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease.

Regueiro M, Valentine J, Plevy S, Fleisher MR, Lichtenstein GR. Regueiro M, et al. Among authors: lichtenstein gr. Am J Gastroenterol. 2003 Aug;98(8):1821-6. doi: 10.1111/j.1572-0241.2003.07581.x. Am J Gastroenterol. 2003. PMID: 12907338

8

The effects of infliximab maintenance therapy on health-related quality of life.

Feagan BG, Yan S, Bala M, Bao W, Lichtenstein GR. Feagan BG, et al. Among authors: lichtenstein gr. Am J Gastroenterol. 2003 Oct;98(10):2232-8. doi: 10.1111/j.1572-0241.2003.07674.x. Am J Gastroenterol. 2003. PMID: 14572573 Clinical Trial.

9

Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease.

Rutgeerts P, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Hanauer SB. Rutgeerts P, et al. Among authors: lichtenstein gr. Gastroenterology. 2004 Feb;126(2):402-13. doi: 10.1053/j.gastro.2003.11.014. Gastroenterology. 2004. PMID: 14762776 Clinical Trial.

10

Outcome of pregnancy in women receiving infliximab for the treatment of Crohn's disease and rheumatoid arthritis.

Katz JA, Antoni C, Keenan GF, Smith DE, Jacobs SJ, Lichtenstein GR. Katz JA, et al. Among authors: lichtenstein gr. Am J Gastroenterol. 2004 Dec;99(12):2385-92. doi: 10.1111/j.1572-0241.2004.30186.x. Am J Gastroenterol. 2004. PMID: 15571587

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

452 results

Search Page

Filters